Send to

Choose Destination
See comment in PubMed Commons below
Biol Ther. 2014 Dec;4(1-2):69-71. doi: 10.1007/s13554-014-0015-3. Epub 2014 Apr 23.

To the Editor; A Commentary on "Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden".

Author information

  • 1Pfizer AB, Stockholm, Sweden.
  • 2Pfizer Ltd, Tadworth, UK.
  • 3Pfizer, Brussels, Belgium.
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk